Position in REPL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$4,446,255
-$1,427,666 QoQ
Shares Held
581,210
-3.8% QoQ
Ownership
0.692%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. REPL ranks #156 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in REPL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,446,255 | 581,210 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,873,921 | 604,313 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,777,829 | 901,630 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,261,158 | 243,397 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,445,973 | 148,305 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,155,863 | 95,447 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $997,545 | 91,017 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $209,043 | 23,227 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,006,445 | 367,986 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,858,199 | 220,427 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,025,624 | 59,943 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $643,982 | 27,734 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,494,282 | 84,614 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,617,339 | 59,461 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $113,169 | 6,553 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $491,135 | 28,097 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,603,472 | 94,433 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,705,294 | 62,926 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $817,649 | 27,586 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $310,164 | 8,073 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,361,508 | 44,625 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $101,288 | 2,655 | Shares | Defined | 2021-02-11 | |
| 2020-06-30 | $164,556 | 6,622 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $402,169 | 40,338 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||